OncoCyte Corp (OCX)
2.90
-0.10
(-3.33%)
USD |
NASDAQ |
Nov 04, 16:00
2.82
-0.08
(-2.76%)
Pre-Market: 20:00
OncoCyte Profit Margin (Quarterly): -4.36K% for June 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -4.36K% |
| March 31, 2024 | -5.19K% |
| December 31, 2023 | -5.09K% |
| September 30, 2023 | -1.51K% |
| June 30, 2023 | -1.80K% |
| March 31, 2023 | |
| December 31, 2022 | -16.42K% |
| September 30, 2022 | -13.93K% |
| June 30, 2022 | -3.50K% |
| Date | Value |
|---|---|
| March 31, 2022 | -2.71K% |
| December 31, 2021 | |
| September 30, 2021 | -1.40K% |
| June 30, 2021 | -516.9% |
| March 31, 2021 | -348.7% |
| December 31, 2020 | -1.25K% |
| September 30, 2020 | -1.22K% |
| June 30, 2020 | -6.37K% |
| March 31, 2020 | -48.32K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-48.32K%
Minimum
Mar 2020
-348.7%
Maximum
Mar 2021
-7.12K%
Average
-3.11K%
Median
Profit Margin (Quarterly) Benchmarks
| Fonar Corp | 3.20% |
| XWELL Inc | -21.50% |
| ProPhase Labs Inc | -248.7% |
| Applied DNA Sciences Inc | -- |
| Veracyte Inc | 5.01% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -132.9% |
| Return on Assets | -46.37% |
| Return on Invested Capital | -132.9% |
| Gross Profit Margin (Quarterly) | 48.08% |
| Operating Margin (Quarterly) | -5.45K% |
| Return on Net Operating Assets | -56.80% |